Last updated: April 16, 2025
Sponsor: George Washington University
Overall Status: Active - Recruiting
Phase
3
Condition
N/ATreatment
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
Intercostal nerve block
Clinical Study ID
NCT06810375
NCR246143
Ages 18-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Video assisted pulmonary resection, pleurodesis or decortication
Exclusion
Exclusion Criteria:
Allergy to local anesthetics
Patient undergoing bilateral surgery
Surgery is emergent as deemed by the principal investigator
Study Design
Total Participants: 120
Treatment Group(s): 2
Primary Treatment: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
Phase: 3
Study Start date:
March 01, 2025
Estimated Completion Date:
February 28, 2029
Connect with a study center
The George Washington University Hospital
Washington, District of Columbia 20037
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.